Compounds > dextroamphetamine
Page last updated: 2024-08-17

dextroamphetamine and carbostyril

dextroamphetamine has been researched along with carbostyril in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's4 (44.44)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bielecka, Z; Chojnacka-Wójcik, E; Dereń-Wesołek, A; Kłodzińska, A; Maćkowiak, M; Mokrosz, JL; Paluchowska, MH1
Glaser, PE; Lile, JA; Rush, CR; Stoops, WW1
Stoops, WW1
Elkashef, A; Hanson, G; Tiihonen, J; Vocci, F; White, J; Wickes, W1
Evenden, J; Jonak, G; Ross, L; Zhou, J1
Mavrikaki, M; Nomikos, GG; Panagis, G1
Glaser, PE; Hays, LR; Lile, JA; Rush, CR; Stoops, WW1
Bäckström, P; Etelälahti, TJ; Hyytiä, P1
Charntikov, S; Crawford, CA; Der-Ghazarian, T; Lee, RJ; McDougall, SA; Varela, FA1

Reviews

1 review(s) available for dextroamphetamine and carbostyril

ArticleYear
Pharmacotherapy of methamphetamine addiction: an update.
    Substance abuse, 2008, Volume: 29, Issue:3

    Topics: Antipsychotic Agents; Aripiprazole; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug Therapy; Humans; Lobeline; Methamphetamine; Methylphenidate; Narcotic Antagonists; Nicotinic Agonists; Piperazines; Prevalence; Quinolones; Recurrence; Substance-Related Disorders

2008

Other Studies

8 other study(ies) available for dextroamphetamine and carbostyril

ArticleYear
Structure-activity relationship studies of CNS agents. XII. 1-[4-(4-aryl-1-piperazinyl)butyl]-3,4-dihydro-2(1H)-quinolinones: new 5-HT1A, 5-HT2 and D2 ligands with a potential antipsychotic activity.
    Drug design and discovery, 1994, Volume: 11, Issue:3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Dextroamphetamine; Dopamine D2 Receptor Antagonists; In Vitro Techniques; Male; Motor Activity; Quinolones; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D1; Reserpine; Serotonin Antagonists; Tryptamines

1994
A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.
    Drug and alcohol dependence, 2006, Sep-15, Volume: 84, Issue:2

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Pressure; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Rate; Humans; Male; Piperazines; Quinolones; Substance-Related Disorders; Surveys and Questionnaires

2006
Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.
    Experimental and clinical psychopharmacology, 2006, Volume: 14, Issue:4

    Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Area Under Curve; Aripiprazole; Central Nervous System Stimulants; Dextroamphetamine; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Humans; Piperazines; Psychomotor Performance; Quinolones

2006
A novel operant conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogenic effects of drugs.
    Behavioural pharmacology, 2009, Volume: 20, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Aripiprazole; Benzodiazepines; Chlordiazepoxide; Conditioning, Operant; Conflict, Psychological; Dextroamphetamine; Diazepam; Electroshock; Flumazenil; Male; Piperazines; Punishment; Pyridazines; Quinolones; Rats; Rats, Sprague-Dawley; Triazoles; Yohimbine

2009
Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania.
    The international journal of neuropsychopharmacology, 2010, Volume: 13, Issue:4

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Locomotion; Male; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Self Stimulation

2010
Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans.
    Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:11

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Behavior; Blood Pressure; Cardiovascular System; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Discrimination Learning; Female; Heart Rate; Humans; Male; Middle Aged; Piperazines; Quinolones; Substance-Related Disorders; Surveys and Questionnaires

2011
Attenuation of reinforcing and psychomotor stimulant effects of amphetamine by aripiprazole.
    Addiction biology, 2011, Volume: 16, Issue:1

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Brain; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Male; Motivation; Motor Activity; Piperazines; Psychomotor Performance; Quinolones; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Reinforcement, Psychology; Self Administration; Sucrose

2011
Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats.
    Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:4

    Topics: Age Factors; Animals; Antipsychotic Agents; Aripiprazole; Binding Sites; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Female; Haloperidol; Male; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Time Factors; Up-Regulation

2014